Jove
Visualize
Contact Us

Related Experiment Videos

Protein binding: what does it mean?

R T Scheife1

  • 1Tufts University School of Medicine, Boston, MA.

DICP : the Annals of Pharmacotherapy
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Drug protein binding significantly impacts how medications work. High binding affects tissue penetration and drug half-life, while low binding leads to faster excretion, influencing clinical effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction. Notice of duplicate publication.

Mayo Clinic proceedings·2000
Same author

Impact of Parkinson's disease and its pharmacologic treatment on quality of life and economic outcomes.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
Same author

Clinical management of Parkinson's disease. Introduction.

Pharmacotherapy·1999
Same author

Successful orchestration of antiparkinsonian pharmacotherapy.

Pharmacotherapy·1999
Same author

Clinical pharmacy: just what the patient ordered.

Pharmacotherapy·1999
Same author

Photosensitizing potential of ofloxacin.

International journal of dermatology·1993
Same journal

Eradication of methicillin-resistant Staphylococcus aureus vaginitis with mupirocin.

DICP : the annals of pharmacotherapy·1991
Same journal

Ketorolac formulary restriction and usage evaluation.

DICP : the annals of pharmacotherapy·1991
Same journal

Oral vancomycin-induced rash: case report and review of the literature.

DICP : the annals of pharmacotherapy·1991
Same journal

Imipenem/cilastatin drug utilization evaluation in a large community hospital.

DICP : the annals of pharmacotherapy·1991
Same journal

Pharmacist involvement in Society of Critical Care Medicine.

DICP : the annals of pharmacotherapy·1991
Same journal

Early anticoagulation therapy in deep vein thrombosis.

DICP : the annals of pharmacotherapy·1991
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Clinical Pharmacy

Background:

  • Drug performance is influenced by protein binding.
  • High protein binding can limit tissue penetration but prolong half-life.
  • Low protein binding enhances tissue penetration but increases excretion rate.

Purpose of the Study:

  • To elucidate the clinical significance of drug protein binding.
  • To understand how varying degrees of protein binding affect drug pharmacokinetics.
  • To highlight the importance of considering protein binding in drug evaluation.

Main Methods:

  • Review of pharmacokinetic principles related to drug-protein interactions.
  • Analysis of the relationship between protein binding percentage and clinical outcomes.

Related Experiment Videos

  • Consideration of factors affecting plasma protein concentrations.

    • Main Results:

    • Drugs with <80-85% protein binding show minimal clinical differences.
    • Highly protein-bound agents exhibit significant variations in tissue penetration and half-life compared to minimally bound agents.
    • Binding to non-albumin plasma proteins can occur.

    Conclusions:

    • Free drug concentration is a more accurate measure of clinical effect when plasma protein levels fluctuate.
    • Clinicians and formulary committees must understand protein binding dynamics for optimal drug selection.
    • Qualitative and quantitative differences in protein binding are critical for evaluating drug efficacy.